Bellicum Pharma (BLCM) Tops Q4 EPS by 8c

Bellicum Pharma (NASDAQ: BLCM) reported Q4 EPS of ($0.66), $0.08 better than the analyst estimate of ($0.74).

For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Core & Main, Inc (CNM) Tops Q3 EPS by 2c ; Offers Guidance
• Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance